anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
RayzeBio · pitchdeck

RayzeBio | IPO Presentation Deck | 41 slides

41 pages · 4 arc beats · 3 loops

Pitchdeck Download JSON
Unlock

RayzeBio | IPO Presentation Deck | 41 slides

RayzeBio · 2023-09
arc beats above · slides in the middle · loops below · scroll → 3 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON
Narrative range 12 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem 4 slides 100% 4/4 slides 100% 4/4 slides · 16 hits
— 0/4 slides
— 0/4 slides
100% 4/4 slides 100% 4/4 slides 75% 3/4 slides Solution 6 slides 100% 6/6 slides 100% 6/6 slides · 25 hits
— 0/6 slides
33.3% 2/6 slides 33.3% 2/6 slides 100% 6/6 slides 83.3% 5/6 slides Market Sizing 1 slides 100% 1/1 slides 100% 1/1 slides · 8 hits
— 0/1 slides
100% 1/1 slides
— 0/1 slides
100% 1/1 slides
— 0/1 slides
Team 1 slides 100% 1/1 slides 100% 1/1 slides · 6 hits
— 0/1 slides
— 0/1 slides
— 0/1 slides
100% 1/1 slides
— 0/1 slides

Slide inventory

41
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detail
02
other
Open slide detail
03
This is a standard IPO/follow-on offering summary table.plan_implementation
Open slide detail
04
The slide uses a structured table format to present key company metrics and status.summarize
Open slide detail
05
present_solution
Open slide detail
06
The slide uses a Gantt-style visualization for drug development stages.plan_implementation
Open slide detail
07
Uses a visual metaphor of 'Outside in' vs 'Precise from within' to contrast the two treatment modalities.compare_peers
Open slide detail
08
The slide uses a simple comparison framework to highlight clinical benefits.compare_peers
Open slide detail
09
The slide uses a comparison framework to justify the use of alpha-emitting isotopes in targeted radiotherapy.frame_problem
Open slide detailBeat · Problem
10
The slide uses a chronological progression of therapeutic classes (Targeted, Immuno-oncology, ADCs, Cell Therapy) leading to RPT.argue_timing
Open slide detailBeat · ProblemLoop · Why Now
11
The slide uses a comparison table to validate the market potential of the radiopharmaceutical space by highlighting a competitor's success.show_traction
Open slide detailBeat · ProblemLoop · Why Now
12
The slide uses a process flow diagram to show the standard of care progression for two types of NETs.frame_problem
Open slide detailBeat · ProblemLoop · Cost Of Inaction
13
The slide uses a Kaplan-Meier curve to contrast Lutathera against a control group, highlighting the clinical limitation of the current standard of care.frame_problem
Open slide detailLoop · Cost Of Inaction
14
The chart compares median progression vs median survival in months across three patient cohorts (Pancreatic, GI, Overall).size_opportunity
Open slide detailLoop · Cost Of Inaction
15
The slide uses a chemical structure comparison to illustrate the similarity in binder/chelator while highlighting the difference in radioisotope.present_solution
Open slide detailBeat · Solution
16
The slide uses a process-oriented layout to show the transition between trial phases.plan_implementation
Open slide detailBeat · SolutionLoop · Hypothesis Test
17
The table specifically highlights that there were zero treatment-related serious adverse events (SAE) and zero discontinuations.analyze_data
Open slide detailBeat · SolutionLoop · Hypothesis Test
18
Waterfall plot displays individual patient responses; benchmarking table compares ORR against historical standards.show_traction
Open slide detailBeat · SolutionLoop · Hypothesis Test
19
The chart tracks patient follow-up in weeks, with markers indicating dose, dose reduction, and clinical response (Partial Response, Progressive Disease, Stable show_traction
Open slide detailBeat · SolutionLoop · Hypothesis Test
20
compare_peers
Open slide detailBeat · SolutionLoop · Hypothesis Test
21
The slide uses a standard clinical trial flow diagram (Population -> Treatment -> Endpoints -> Crossover).plan_implementation
Open slide detailLoop · Hypothesis Test
22
The slide uses a three-column layout to break down the market opportunity into patient population, pricing, and launch dynamics.size_opportunity
Open slide detailBeat · Market Sizing
23
The slide highlights that 47% of SCLC samples show some level of SSTR2 expression, with 27% showing high expression.analyze_data
Open slide detail
24
Includes a visual case study with PET scan images showing tumor reduction.show_traction
Open slide detail
25
The chart shows tumor growth over 57 days across four treatment groups, with the combination therapy (green line) demonstrating the most effective tumor suppresshow_traction
Open slide detail
26
The slide outlines a clinical trial protocol for a combination therapy involving RYZ101, chemotherapy, and PD-L1 inhibitors.plan_implementation
Open slide detail
27
Includes PET scan imagery and a pharmacokinetic tumor uptake graph comparing RAYZ-SSTR to DOTATATE.present_solution
Open slide detail
28
CMC stands for Chemistry, Manufacturing, and Controls. The slide highlights infrastructure investment and current CDMO reliance.present_solution
Open slide detail
29
The workflow includes a feedback loop from in vivo screening back to binder discovery.present_solution
Open slide detail
30
The slide uses a staircase-style diagram to represent progression in clinical relevance of data.plan_implementation
Open slide detail
31
Includes IHC staining images and a waterfall plot showing tumor shrinkage.present_solution
Open slide detail
32
The slide demonstrates the efficacy and specificity of the drug candidate in a preclinical model.present_solution
Open slide detail
33
Comparison of 225Ac vs 177Lu efficacy at significantly different dose levels.show_traction
Open slide detail
34
Includes clinical imaging examples for two patients.show_traction
Open slide detail
35
The slide uses a longitudinal imaging sequence to demonstrate drug efficacy/retention.show_traction
Open slide detail
36
The slide uses a process flow diagram to illustrate the regulatory and clinical milestones.plan_implementation
Open slide detail
37
The slide lists 24 investor logos/names.show_traction
Open slide detail
38
plan_implementation
Open slide detail
39
Includes 88 FTEs count and board member list.other
Open slide detailBeat · Team
40
The slide uses a vertical process flow to illustrate vertical integration.present_solution
Open slide detail
41
This is a closing or transition slide featuring the company logo and mission statement.inspire_vision
Open slide detail